研報掘金丨華西證券:首予香農芯創“增持”評級,“分銷+產品”業務雙受益
華西證券研報指出,香農芯創是國內領先的電子元器件分銷企業,深耕高端存儲領域。當下在AI的驅動下,存儲芯片的市場規模和需求有望進一步擴大。公司作爲國內核心存儲原廠分銷商,有望充分受益行業週期上行以及存儲市場規模增長帶來的高端存儲需求擴張。2023年公司聯合深圳大普微等公司共同成立海普存儲,目前開發進展順利,已完成企業級DDR4、DDR5、Gen4eSSD的研發、試產。用於雲計算存儲(數據中心服務器)等領域。目前已完成部分國內主要的服務器平臺的認證和適配工作並正式進入產品量產階段。伴隨企業級存儲需求的擴張,公司有望通過設立海普存儲打開成長空間。首次覆蓋,給予“增持”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.